{"id":"https://openalex.org/W2610446904","doi":null,"title":"Neuraminidase inhibitors: Oseltamivir, Peramivir, Synthesis and Profile","display_name":"Neuraminidase inhibitors: Oseltamivir, Peramivir, Synthesis and Profile","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2610446904","mag":"2610446904"},"language":"en","primary_location":{"id":"mag:2610446904","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Prince_Sharma2/publication/203484923_Neuraminidase_inhibitors_Oseltamivir_Peramivir_Synthesis_and_Profile/links/53d892af0cf2631430c324d8.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062586117","display_name":"Prince Prashant Sharma","orcid":"https://orcid.org/0000-0002-4261-1809","observed_orcids":["https://orcid.org/0000-0002-4261-1809"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prince Prashant Sharma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4261-1809","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Rumi Roy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rumi Roy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2089,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57774751,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuraminidase-inhibitors","display_name":"neuraminidase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/oseltamivir","display_name":"oseltamivir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peramivir","display_name":"peramivir","score":1.0},{"id":"https://openalex.org/keywords/influenza-a-virus","display_name":"influenza A virus","score":0.7009999752044678},{"id":"https://openalex.org/keywords/influenza-b","display_name":"influenza B","score":1.0},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.8209999799728394},{"id":"https://openalex.org/keywords/influenza-treatment","display_name":"influenza treatment","score":0.6169999837875366},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/drug-profile","display_name":"drug profile","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.9442887306213379},{"id":"https://openalex.org/C2780374985","wikidata":"https://www.wikidata.org/wiki/Q211509","display_name":"Oseltamivir","level":5,"score":0.8926215171813965},{"id":"https://openalex.org/C2777538117","wikidata":"https://www.wikidata.org/wiki/Q425196","display_name":"Neuraminidase inhibitor","level":5,"score":0.7910985946655273},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.7308239340782166},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7135793566703796},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5882812738418579},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5551314353942871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2727268934249878},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.16211184859275818},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.14945343136787415},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.06682714819908142}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2610446904","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Prince_Sharma2/publication/203484923_Neuraminidase_inhibitors_Oseltamivir_Peramivir_Synthesis_and_Profile/links/53d892af0cf2631430c324d8.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1523679951","https://openalex.org/W1967579117","https://openalex.org/W2012595691","https://openalex.org/W2027368298","https://openalex.org/W2030867539","https://openalex.org/W2048679896","https://openalex.org/W2052187559","https://openalex.org/W2054538936","https://openalex.org/W2057754476","https://openalex.org/W2064956973","https://openalex.org/W2072658090","https://openalex.org/W2073723291","https://openalex.org/W2081460129","https://openalex.org/W2104397822","https://openalex.org/W2105466816","https://openalex.org/W2107176682","https://openalex.org/W2118731850","https://openalex.org/W2129482297","https://openalex.org/W2139639793","https://openalex.org/W2154288940","https://openalex.org/W2156231263","https://openalex.org/W2157172978","https://openalex.org/W2157177671","https://openalex.org/W2949524476"],"related_works":["https://openalex.org/W2900774371","https://openalex.org/W2733732911","https://openalex.org/W7023567471","https://openalex.org/W1514950964","https://openalex.org/W7163992061","https://openalex.org/W7067836178","https://openalex.org/W2409016895","https://openalex.org/W2104891603","https://openalex.org/W2070880385","https://openalex.org/W2048152942"],"abstract_inverted_index":{"According":[0],"to":[1,23,54,80],"the":[2,13,71,81,89],"Centre":[3],"for":[4,62,93,109],"Disease":[5],"Control":[6],"and":[7,28,49,66,76,97,112],"Prevention":[8],"(CDC),":[9],"every":[10],"year":[11],"in":[12,52],"United":[14],"States":[15],"more":[16],"than":[17,39],"200,000":[18],"people":[19,34],"are":[20,60,87],"hospitalized":[21,110],"due":[22],"influenza":[24,46,64,74],"or":[25],"its":[26,78],"complications,":[27],"of":[29,73,115],"this":[30],"number":[31],"about":[32],"36,000":[33],"die":[35],"each":[36],"year.":[37],"Other":[38],"amantadine,":[40],"another":[41],"anti-influenzal":[42],"agent":[43],"only":[44,108],"inhibits":[45],"A":[47,65],"virus":[48,75],"not":[50],"B,":[51],"contrast":[53],"previous":[55],"therapies,":[56],"Neuraminidase":[57,68],"(NA)":[58],"inhibitors":[59,69,86],"effective":[61],"both":[63],"B.":[67],"check":[70],"discharge":[72],"inhibit":[77],"spreading":[79],"normal":[82],"cells.":[83],"Two":[84],"neuraminidase":[85],"on":[88],"market":[90],"as":[91],"drugs":[92],"influenza:":[94],"Peramivir":[95,102],"(BioCryst)":[96],"Oseltamivir":[98],"(Tamiflu\u00ae,":[99],"Gilead/Roche).":[100],"However,":[101],"(I.V.)":[103],"is":[104],"recently":[105],"approved":[106],"precisely":[107],"adult":[111],"pediatric":[113],"patients":[114],"Flu":[116],"(SEASONAL":[117],"INFLUENZA":[118],"/":[119],"I.V.).":[120]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-05-12T00:00:00"}